Paul S Giacomini
9PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 10, 2026
Eye tracking as a digital biomarker in neurodegenerative diseases.Paul S Giacomini, Patrice Voss, Virginia Devonshire
|May 22, 2024
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.Jiwon Oh, Virender Bhan, Anthony Traboulsee
|Apr 17, 2023
Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in?Paul S Giacomini, Jiwon Oh, Sarah A Morrow
|Jan 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.Koji Shinoda, Rui Li, Ayman Rezk
|Jul 29, 2022
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.Ian J Tagge, Ilana R Leppert, Dumitru Fetco
|Mar 01, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.Stephen L Hauser, Anne H Cross, Kevin Winthrop
Pageof 2
Frequent Collaborators
2 joint publications
Anne H Cross
2 joint publications
Sarah A Morrow
1 joint publications
T Berger
1 joint publications
Mathab Ghadiri
1 joint publications
Frauke Zipp
1 joint publications
Stephen L Hauser
1 joint publications
Heinz Wiendl
1 joint publications
Francesco Saccà
1 joint publications
Roman Willi
1 joint publications
Ludwig Kappos
